Pages that link to "Q35484837"
Jump to navigation
Jump to search
The following pages link to Hippo signaling pathway in liver and pancreas: the potential drug target for tumor therapy (Q35484837):
Displaying 6 items.
- Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway (Q36689006) (← links)
- Designing Visible Light-Cured Thiol-Acrylate Hydrogels for Studying the HIPPO Pathway Activation in Hepatocellular Carcinoma Cells (Q37282950) (← links)
- Molecular Features of the YAP Inhibitor Verteporfin: Synthesis of Hexasubstituted Dipyrrins as Potential Inhibitors of YAP/TAZ, the Downstream Effectors of the Hippo Pathway (Q38882539) (← links)
- Targeting multiple effector pathways in pancreatic ductal adenocarcinoma with a G-quadruplex-binding small molecule. (Q48195145) (← links)
- Modular and Adaptable Tumor Niche Prepared from Visible Light Initiated Thiol-Norbornene Photopolymerization (Q49731574) (← links)
- Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RAS expression, and kills pancreatic and blood cancer cells (Q93116754) (← links)